Specifically, individuals with positive family history (especially those who are BRCA1/BRCA2 mutation negative), patients with bilateral disease, and patients with a family history of male breast cancer had a higher occurrence of 1100delC variants as compared with control individuals. This evidence concerns the gene BRCA1 and male breast carcinoma.